Baguio General Hospital and Medical Center, also known as Baguio General Hospital, is a hospital in Baguio, Philippines. It is the largest government funded tertiary hospital in the Northern Luzon Region.

There are 800 (To be increased to 1500) beds in Baguio General Hospital and Medical Center.

During the past decade, Baguio General Hospital and Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baguio General Hospital and Medical Center" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "CHIMES Society" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "PT Kalbe Genexine Biologics" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baguio General Hospital and Medical Center" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator, "National Medical Research Council (NMRC), Singapore" with 1 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator and "Synermore Biologics USA Limited" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Baguio General Hospital and Medical Center" are "Anaemia Associated With Chronic Kidney Disease" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cerebral Infarction" (1 trials), "Cerebral Venous Thrombosis" (1 trials) and "Complicated Intra-abdominal Infection" (1 trials). Many other conditions were trialed in "Baguio General Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Baguio General Hospital and Medical Center" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATM-AVI" (1 trials), "Afatinib" (1 trials), "COL" (1 trials), "Carboplatin" (1 trials) and "EU-approved Avastin®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baguio General Hospital and Medical Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Baguio General Hospital and Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Baguio General Hospital and Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baguio General Hospital and Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".